Starlight Cardiovascular announced today that it has closed the first $9.48M in an $11.45M Series A financing, which will be used to progress development of its portfolio of pediatric interventional cardiology devices. The financing is led by Bird B and included conversion of previously-issued notes.

Starlight Cardiovascular is developing a portfolio of minimally-invasive devices to address the heterogenous clinical needs in pediatric CHD. About Starlight CardiovascularStarlight Cardiovascular is a preclinical stage medical technology company developing a portfolio of devices to address pediatric Congenital Heart Disease.

www.starlightcardio.com

Medical Device

Medical

Starlight Cardiovascular Secures $9.48M In Series A Financing To Advance Pediatric Health

Description

Company Information

Related People

Starlight Cardiovascular Secures $9.48M In Series A Financing To Advance Pediatric Health

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Company Information